BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 1998683)

  • 1. Interaction of human placental ribonuclease with placental ribonuclease inhibitor.
    Shapiro R; Vallee BL
    Biochemistry; 1991 Feb; 30(8):2246-55. PubMed ID: 1998683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tryptophan fluorescence as a probe of placental ribonuclease inhibitor binding to angiogenin.
    Lee FS; Auld DS; Vallee BL
    Biochemistry; 1989 Jan; 28(1):219-24. PubMed ID: 2706245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tight-binding inhibition of angiogenin and ribonuclease A by placental ribonuclease inhibitor.
    Lee FS; Shapiro R; Vallee BL
    Biochemistry; 1989 Jan; 28(1):225-30. PubMed ID: 2706246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of placental ribonuclease inhibitor to the active site of angiogenin.
    Lee FS; Vallee BL
    Biochemistry; 1989 Apr; 28(8):3556-61. PubMed ID: 2742853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of human placental ribonuclease inhibitor in Escherichia coli.
    Lee FS; Vallee BL
    Biochem Biophys Res Commun; 1989 Apr; 160(1):115-20. PubMed ID: 2653313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human placental ribonuclease inhibitor abolishes both angiogenic and ribonucleolytic activities of angiogenin.
    Shapiro R; Vallee BL
    Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2238-41. PubMed ID: 3470787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification of mammalian ribonuclease using immobilized human ribonuclease inhibitor.
    Nadano D; Yasuda T; Takeshita H; Sawazaki K; Kishi K
    Protein Expr Purif; 1996 Mar; 7(2):167-72. PubMed ID: 8812855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic characterization of two active mutants of placental ribonuclease inhibitor that lack internal repeats.
    Lee FS; Vallee BL
    Biochemistry; 1990 Jul; 29(28):6633-8. PubMed ID: 2397204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of bovine angiogenin using a placental ribonuclease inhibitor binding assay.
    Bond MD; Vallee BL
    Biochemistry; 1988 Aug; 27(17):6282-7. PubMed ID: 3064806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An in vitro binding assay for angiogenin using placental ribonuclease inhibitor.
    Bond MD
    Anal Biochem; 1988 Aug; 173(1):166-73. PubMed ID: 3189795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ribonuclease inhibitor from human placenta. Purification and properties.
    Blackburn P; Wilson G; Moore S
    J Biol Chem; 1977 Aug; 252(16):5904-10. PubMed ID: 560377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribonuclease inhibitors from the livers of five mammalian species.
    Burton LE; Fucci NP
    Int J Pept Protein Res; 1982 Apr; 19(4):372-9. PubMed ID: 7118407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of human pancreatic ribonuclease by the human ribonuclease inhibitor protein.
    Johnson RJ; McCoy JG; Bingman CA; Phillips GN; Raines RT
    J Mol Biol; 2007 Apr; 368(2):434-49. PubMed ID: 17350650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of a human colon carcinoma-secreted enzyme with pancreatic ribonuclease-like activity.
    Shapiro R; Fett JW; Strydom DJ; Vallee BL
    Biochemistry; 1986 Nov; 25(23):7255-64. PubMed ID: 3467790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and characterization of a ribonuclease from human liver.
    Sorrentino S; Tucker GK; Glitz DG
    J Biol Chem; 1988 Nov; 263(31):16125-31. PubMed ID: 3182786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the N terminus in RNase A homologues: differences in catalytic activity, ribonuclease inhibitor interaction and cytotoxicity.
    Boix E; Wu Y; Vasandani VM; Saxena SK; Ardelt W; Ladner J; Youle RJ
    J Mol Biol; 1996 Apr; 257(5):992-1007. PubMed ID: 8632481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ribonuclease inhibitor from bovine brain.
    Burton LE; Blackburn P; Moore S
    Int J Pept Protein Res; 1980 Nov; 16(5):359-64. PubMed ID: 7216611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site-specific mutagenesis reveals differences in the structural bases for tight binding of RNase inhibitor to angiogenin and RNase A.
    Chen CZ; Shapiro R
    Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1761-6. PubMed ID: 9050852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the interactions of human ribonuclease inhibitor with angiogenin and ribonuclease A by mutagenesis: importance of inhibitor residues inside versus outside the C-terminal "hot spot".
    Shapiro R; Ruiz-Gutierrez M; Chen CZ
    J Mol Biol; 2000 Sep; 302(2):497-519. PubMed ID: 10970748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary structure of human placental ribonuclease inhibitor.
    Lee FS; Fox EA; Zhou HM; Strydom DJ; Vallee BL
    Biochemistry; 1988 Nov; 27(23):8545-53. PubMed ID: 3219362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.